Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population.
Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population.
复制标题
CKIP-1 P21A 多态性与中国人群慢性心力衰竭风险的关联
DOI:
10.18632/oncotarget.16614
复制
发表时间:
2017-05-30
期刊:
影响因子:
--
通讯作者:
Chen XP
中科院分区:
文献类型:
--
作者:
Li MP;Zhang YJ;Hu XL;Zhou JP;Yang YL;Peng LM;Qi H;Yang TL;Chen XP
Pathological cardiac hypertrophy is an independent risk factor for chronic heart failure. Casein kinase-2 interacting protein-1 (CKIP-1) can inhibit pathological cardiac hypertrophy. Therefore, we investigated whether CKIP-1 nonsynonymous polymorphism rs2306235 (Pro21Ala) contributes to risk and prognosis of chronic heart failure in a Chinese population.A total of 923 adult patients with chronic heart failure and 1020 age- and gender-matched healthy controls were recruited. CKIP-1 rs2306235 polymorphism was genotyped using PCR-restriction fragment length polymorphism. Additional follow-up data for 140 chronic heart failure patients was evaluated. The rs2306235 G allele was associated with an increased risk of chronic heart failure (OR = 1.38, 95% CI = 1.09-1.75, p = 0.007), especially in patients with hypertension (OR = 1.45, 95% CI = 1.09-1.75, p = 0.006) and coronary heart disease (OR = 1.41, 95% CI = 1.09-1.83, p = 0.010) after adjustment for multiple cardiovascular risk factors. However, rs2306235 polymorphism was not associated with cardiovascular mortality in chronic heart failure (p = 0.875). CKIP-1 rs2306235 polymorphism may be a risk factor for chronic heart failure in a Chinese Han population.